Maternal Sepsis: Early Recognition and Antibiotic Therapy

Maternal sepsis is a time-critical complication in which infection triggers organ dysfunction during pregnancy, labor, after birth, or following pregnancy loss. The clinical picture can deteriorate quickly, while normal pregnancy changes may make early warning signs less obvious. Prompt recognition, rapid assessment, effective antimicrobial treatment, and coordinated escalation are central to protecting the mother and baby.

Perinatal teams must think beyond fever. A patient with infection may present with breathlessness, confusion, reduced urine output, hypotension, severe pain, or an unusually fast heart rate. Some patients are afebrile, particularly after taking antipyretics or when an infection is already advanced. A structured approach helps clinicians identify risk before shock develops.

The scientific focus associated with the FAOPS 2020 congress included perinatal and neonatal medicine, research, and outcomes across the Asia-Pacific region. Although the Tokyo meeting was canceled in April 2020 because of the COVID-19 pandemic and international travel difficulties, its clinical themes remain highly relevant to obstetric and neonatal practice.

Why Maternal Sepsis Requires Fast Thinking

Sepsis may arise from chorioamnionitis, endometritis, urinary infection, pneumonia, wound infection, mastitis, septic abortion, or an intra-abdominal source. Obstetric procedures, cesarean birth, prolonged rupture of membranes, retained products of conception, and immunosuppression can increase the likelihood of serious infection. Group A streptococcal disease and other invasive infections may progress with striking speed.

Pregnancy changes baseline physiology. Heart rate, respiratory rate, plasma volume, renal filtration, and white-cell count can differ from nonpregnant values. A “normal” adult threshold may therefore be misleading, while an apparently modest abnormality can carry significance when it is new or worsening. Clinicians should compare findings with the patient’s usual condition and examine trends rather than relying on a single number.

Maternal deterioration also threatens fetal well-being. Reduced uteroplacental perfusion, maternal hypoxemia, fever, and hypotension can cause fetal tachycardia, acidemia, or distress. Stabilizing the mother is the priority, but fetal monitoring can provide an important signal that the maternal condition is changing.

Recognizing a Changing Clinical Picture

Early assessment should include airway, breathing, circulation, mental status, temperature, urine output, pain, and the suspected site of infection. Concerning features include new confusion, mottled or clammy skin, persistent tachycardia, increased work of breathing, oxygen desaturation, low blood pressure, oliguria, and rising lactate. Severe localized pain or uterine tenderness may point toward an obstetric source even before laboratory results return.

A screening score can support clinical judgment, but it should never replace it. Tools developed for general adult populations may underperform in pregnancy because physiological baselines differ. A woman with suspected infection and a worsening trajectory deserves senior review even if she does not meet every formal scoring threshold.

The differential diagnosis should remain broad. Pulmonary embolism, hemorrhage, hypertensive disease, cardiomyopathy, anaphylaxis, and medication effects can resemble sepsis or occur alongside it. When infection is plausible, treatment should proceed while competing diagnoses are assessed. Waiting for a perfect explanation can allow organ injury to become irreversible.

Respiratory symptoms require particular care during outbreaks of infectious disease. The global COVID-19 review reflects the importance of understanding how maternal infection can affect perinatal outcomes, while also reminding clinicians that viral illness and bacterial co-infection may overlap. Oxygenation, work of breathing, imaging decisions, and isolation precautions should be addressed promptly.

Finding the Source and Taking Cultures

Microbiological samples should be obtained as soon as possible when they can be collected without delaying antimicrobial therapy. Blood cultures, urine culture, wound or vaginal samples when indicated, and respiratory specimens can help refine treatment. Two blood-culture sets from separate sites are commonly considered when feasible, with local policy guiding collection and volume.

Source evaluation depends on the clinical presentation. Ultrasound may identify retained products, pelvic collections, or urinary obstruction. Chest imaging can be appropriate for suspected pneumonia, and abdominal or pelvic imaging may be needed for severe pain, peritonitis, or failure to respond. A surgical or obstetric examination is essential when necrotizing infection, wound breakdown, uterine infection, or retained tissue is possible.

Laboratory testing may include complete blood count, renal and liver function, coagulation studies, blood gas analysis, glucose, and lactate. Lactate can support assessment of hypoperfusion, but it should be interpreted with pregnancy, labor, medications, and other causes in mind. Normal laboratory findings do not exclude early sepsis when the patient’s condition is clinically concerning.

Choosing and Delivering Antibiotics

Empiric antibiotics should cover the likely organisms at the suspected source and reflect local resistance patterns, allergies, renal function, gestational age, and recent antimicrobial exposure. In a critically ill patient, broad intravenous therapy is generally started promptly after cultures are taken, provided that obtaining cultures does not create a meaningful delay.

Drug selection requires both urgency and obstetric expertise. Regimens may need activity against gram-positive, gram-negative, and anaerobic organisms in polymicrobial pelvic infection. Severe soft-tissue infection or group A streptococcal disease may require a different combination from uncomplicated pyelonephritis or pneumonia. Infectious disease, obstetric, pharmacy, and critical care input can be valuable when the source is unclear or resistance is likely.

Administration is as important as selection. Delays may occur when a patient is transferred between triage, labor ward, theater, and intensive care. A sepsis pathway should identify who prescribes, who prepares, who administers, and who reassesses. The first dose, time given, allergies, cultures, fluid balance, and response should be documented clearly.

Antibiotic therapy should be reviewed when culture results, imaging, and the clinical course become available. Narrowing the regimen can reduce toxicity and antimicrobial pressure, but de-escalation should not be confused with premature discontinuation. Duration depends on the source, source control, bacteremia, immune status, and response to treatment.

Escalation and Source Control

Initial resuscitation may include oxygen, intravenous access, balanced fluids when appropriate, blood products for hemorrhage or anemia, and vasopressors when hypotension persists. Fluid therapy must be individualized because excessive volume can worsen pulmonary edema, particularly in patients with cardiac disease, preeclampsia, or respiratory infection. Persistent shock warrants critical care involvement and invasive monitoring when indicated.

Antibiotics cannot compensate for an untreated source. Retained products may require evacuation, an abscess may need drainage, an infected cesarean wound may need opening and debridement, and necrotizing infection requires emergency surgery. Multidisciplinary communication should include obstetrics, anesthesia, neonatology, microbiology, surgery, intensive care, and nursing leadership.

Delivery decisions are individualized. Maternal stabilization is usually the immediate priority, and infection alone does not automatically require cesarean birth. The timing and mode of delivery depend on gestational age, fetal condition, labor status, the infection source, and whether delivery contributes to source control. Clear, timely communication with the patient and family remains essential during rapidly changing circumstances.

Prevention, Communication, and Learning

Prevention begins with reliable infection-control practices, appropriate screening and treatment of urinary and genital infections, careful cesarean and wound care, vaccination where recommended, and attention to postpartum symptoms. Patients should receive clear advice about urgent warning signs, including fever or feeling unusually cold, worsening abdominal or pelvic pain, foul-smelling discharge, breathlessness, confusion, faintness, and reduced urination.

The antenatal record should capture allergies, previous resistant organisms, relevant medical conditions, and recent antibiotics. Nutritional and metabolic conditions also influence pregnancy planning and clinical risk. Resources on maternal PKU management illustrate the wider importance of coordinated antenatal care, specialist follow-up, and individualized preparation before complications arise.

Hospitals benefit from simulation drills and regular review of sepsis cases. Audits can examine time to recognition, time to cultures, time to first antibiotic dose, appropriateness of empiric coverage, escalation delays, source-control timing, and maternal and neonatal outcomes. Reviewing near misses is especially valuable because system weaknesses often appear before a fatal event.

Practical Priorities for Clinical Teams

• Use pregnancy-aware vital-sign assessment and respond to worsening trends, not just isolated thresholds.
• Obtain cultures and essential investigations rapidly, but never delay life-saving antibiotics for difficult sampling.
• Choose empiric intravenous therapy according to the suspected source, local resistance data, allergies, renal function, and pregnancy considerations.
• Reassess response frequently, involve senior and critical care clinicians early, and document the time of every major intervention.
• Pursue source control promptly when retained tissue, abscess, infected wounds, obstruction, or necrotizing infection is suspected.

The official FAOPS 2020 congress site preserves the setting in which these perinatal questions were brought together across Asian and Oceania societies. Its focus on scientific exchange is a useful reminder that maternal sepsis care depends on shared protocols, regional surveillance, antimicrobial stewardship, and continuing education.

Every maternity service can strengthen its response by mapping the first hour of care, testing its escalation pathway, and ensuring that antibiotics, cultures, fluids, monitoring, and specialist support are available without avoidable delay. Early action gives mothers the best chance of recovery and protects newborn outcomes when infection threatens two patients at once.